Kobak, ŞenolGüngen, Adil CanDoğan Güngen, BelmaTutpınar, YıldırayGüler, Mehtap2020-09-102020-09-102020Kobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2.0300-9742https://doi.org/10.1080/03009742.2020.1784460https://hdl.handle.net/20.500.12713/1010Sarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported.eninfo:eu-repo/semantics/closedAccessSecukinumab in a patient with sarcoidosisLetter32870066WOS:0005650111000012-s2.0-85090166204Q310.1080/03009742.2020.1784460Q2